Detergent exposure hard on workers' lungs: studies
People who work in detergent factories are at increased risk of developing respiratory problems, including asthma, probably from exposure to chemicals contained in detergent, two new studie...
Reuters via Yahoo! News,
Fri Nov 27 11:18:13 PST 2009
• Found on Yahoo! News
When perfume becomes a nuisance (or a health issue)
Perfume may be a pleasure to those who wear it, but its over-application is often a nuisance to others.
Los Angeles Times,
Fri Nov 27 11:05:52 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News
Professional pesticide use ups risk of nasal woes
When people think about pesticides and health, cancer and birth defects probably come to mind. But new research shows pesticide exposure may contribute to a much more common affliction: itc...
Reuters via Yahoo! News,
Thu Nov 26 09:17:39 PST 2009
• Found on Yahoo! News
STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe
PARIS, November 27 /PRNewswire-FirstCall/ -- Stallergenes has been granted European approval to market Oralair(R) in both adults and children through a Mutual Recognition Procedure.
redOrbit,
Fri Nov 27 05:08:00 PST 2009
• Found on Yahoo! News
TCMs can enhance Western medical treatment - experts
By Karl Zhong Shanghai. November 27. INTERFAX-CHINA - Traditional Chinese medicine (TCM) has an increasingly pivotal role in Western medical treatment, according to experts at the 2009 TCM ...
Interfax,
Fri Nov 27 00:04:42 PST 2009
• Found on Yahoo! News
STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe
Stallergenes has been granted European approval to market Oralair® in both adults and children through a Mutual Recognition Procedure. Germany, the first country where Oralair® has been mar...
PR Newswire via Yahoo! Finance,
Fri Nov 27 01:49:00 PST 2009
• Found on Yahoo! News
Oxagen Raises $26M to Boost Midstage Asthma Compound
LONDON - The flood of new money into European biotechs continued as Oxagen Ltd. announced the completion of a £16 million (US$26.4 million) third-round funding, with new investor Novartis V...
BioWorld,
Tue Nov 24 20:05:21 PST 2009
• Found on Yahoo! News
Cephalon drug posts mixed results in clinical trial
EAST WHITELAND
Daily Local News,
Tue Nov 24 14:42:15 PST 2009
• Found on Yahoo! News
Ception Therapeutics And Cephalon Provide Initial Results Of A Phase IIb/III Study...
Ception Therapeutics, Inc., a privately held biopharmaceutical company, and Cephalon, Inc. (Nasdaq: CEPH) announced results from a Phase IIb/III clinical trial for CINQUIL(TM) (reslizumab) ...
Medical News Today,
Tue Nov 24 04:36:35 PST 2009
• Found on Yahoo! News
Bladder problems
Today we're looking at whether low-dose, continuous oral antibiotic therapy prevents urinary tract infections in predisposed children, Australian research that investigated the overactive b...
Australian Broadcasting Corporation,
Mon Nov 23 20:34:34 PST 2009
• Found on Yahoo! News
Oxagen completes £16 Million Series C round funding
Oxagen Limited, a drug discovery and development company specializing in inflammation, announced today the successful completion of a £16 Million ($26.7 Million) Series C round led by Novar...
News-Medical-Net,
Tue Nov 24 02:39:33 PST 2009
• Found on Yahoo! News
Press Release
MALVERN, Pa. and FRAZER, Pa., Nov. 23 /PRNewswire-FirstCall/ Ception Therapeutics, Inc., a privately held biopharmaceutical company, and Cephalon, Inc. (Nasdaq: CEPH) today announced result...
PharmiWeb,
Tue Nov 24 01:25:07 PST 2009
• Found on Yahoo! News
Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study...
MALVERN, Pa. and FRAZER, Pa., Nov. 23 /PRNewswire-FirstCall/ -- Ception Therapeutics, Inc., a privately held biopharmaceutical company, and Cephalon, Inc.
redOrbit,
Mon Nov 23 08:08:20 PST 2009
• Found on Yahoo! News
Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study...
Ception Therapeutics, Inc., a privately held biopharmaceutical company, and Cephalon, Inc. today announced results from a Phase IIb/III clinical trial for CINQUIL as a treatment for pediatr...
PR Newswire via Yahoo! Finance,
Mon Nov 23 05:00:00 PST 2009
• Found on Yahoo! News
Study on Chronic Respiratory Problems
DUBAI
Khaleej Times,
Sat Nov 21 19:42:24 PST 2009
• Found on Yahoo! News
Circassia Announces Successful Results From Phase II Clinical Study Of ToleroMune(...
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, announced positive results from a recently completed phase II clinical study of its ToleroMune(R) cat allergy therap...
Medical News Today,
Sat Nov 21 04:38:50 PST 2009
• Found on Yahoo! News
Detergent exposure hard on workers' lungs: studies
NEW YORK (Reuters Health) - People who work in detergent factories are at increased risk of developing respiratory problems, including asthma, probably from exposure to chemicals contained ...
Reuters,
Fri Nov 27 13:11:38 PST 2009
• Found on Yahoo! News
Professional pesticide use ups risk of nasal woes
NEW YORK (Reuters Health) - When people think about pesticides and health, cancer and birth defects probably come to mind. But new research shows pesticide exposure may contribute to a much...
Reuters,
Thu Nov 26 09:26:24 PST 2009
• Found on Yahoo! News
Cephalon drug posts mixed results in clinical trial
EAST WHITELAND
Daily Local News,
Tue Nov 24 10:57:26 PST 2009
• Found on Yahoo! News